Firmenprofil zu Eucrates Biomedical Acquisition Corp. Aktie
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Unternehmensdaten
NameEucrates Biomedical Acquisition Corp.
FirmaEucrates Biomedical Acquisition Corp.
SymbolEUCR
Heimatbörse
NASDAQ
ISINVGG3141W1068
WertpapierartAktie
SektorFinancial Services
BrancheShell Companies
CEOParag Phoolchand Saxena MBA, MS
Marktkapitalisierung42 Mio
LandVereinigte Staaten von Amerika
WährungUSD
Mitarbeiter-
Adresse250 West 55th Street, 10019 New York City
IPO Datum2020-12-28
Ticker Symbole
Name
Symbol
NASDAQ
EUCR
Weitere Aktien
Investoren, die Eucrates Biomedical Acquisition Corp. halten, haben auch folgende Aktien im Depot: